10x Genomics gets $50mm in Series D funds, secures $75mm in debt facility
10x Genomics Inc. (genomic discovery) raised $50mm in a Series D financing led by Meritech Capital Partners, which was joined by first-time backer Wells Fargo Strategic Capital and returning shareholders Paladin Capital, Fidelity, and the SoftBank Group. The company also secured a $75mm credit facility with Silicon Valley Bank. 10x will use the proceeds for ongoing product development, global commercialization activities, and expansion of its internal manufacturing operations.
- Research, Analytical Equipment & Supplies
Drug Discovery Tools
- Drug Discovery Tools
- Nonconvertible Debt
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com